Related Experiment Video
Updated: Mar 3, 2026

In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
Epigenetic silencing of protocadherin 10 in colorectal cancer
Xian Zhong1,2, Hong Shen1, Jianshan Mao3
1Department of Medical Oncology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China.
Abstract:
Colorectal cancer (CRC) is one of the most common types of malignant tumor in the world and occurs through a multi-step process resulting from the accumulation of genetic and epigenetic alterations of the genome. Although the molecular mechanisms of the pathogenesis of CRC remain unclear, the inactivation of tumor suppressor genes (TSGs) through promoter methylation serves an important role. Aberrant methylation is a well-defined marker of CRC. At present, the epigenetic silencing of protocadherin 10 (PCDH10) has been identified as an important TSG with key roles in colorectal carcinogenesis, invasion and metastasis as a frequent and early event. Advances in gene methylation detection in tumor tissues and body fluids have led to the development of non-invasive screening methods for CRC. The present study aimed to review the epigenetic alteration of PCDH10 in CRC development, and the potential of PCDH10 to be a non-invasive biomarker for CRC.
Insights
Epigenetic silencing of protocadherin 10 (PCDH10) is crucial in colorectal cancer development. Aberrant PCDH10 methylation may serve as an early, non-invasive biomarker for colorectal cancer screening.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Colorectal cancer (CRC) arises from accumulated genetic and epigenetic alterations.
- Tumor suppressor gene (TSG) inactivation via promoter methylation is a key mechanism in CRC pathogenesis.
- Aberrant DNA methylation is a recognized hallmark of CRC.
Purpose of the Study:
- To review the role of epigenetic alterations in protocadherin 10 (PCDH10) during colorectal cancer development.
- To evaluate the potential of PCDH10 as a non-invasive biomarker for CRC.
Main Methods:
- Literature review focusing on epigenetic modifications in CRC.
- Analysis of studies investigating PCDH10 methylation in colorectal carcinogenesis.
- Examination of research on non-invasive biomarker detection methods.
Main Results:
- Epigenetic silencing of PCDH10, a tumor suppressor gene, is a frequent and early event in colorectal carcinogenesis.
- PCDH10 inactivation plays a significant role in CRC invasion and metastasis.
- Advances in methylation detection offer potential for non-invasive CRC screening.
Conclusions:
- PCDH10 epigenetic alterations are integral to CRC development.
- PCDH10 methylation status holds promise as a non-invasive biomarker for early CRC detection and screening.
More Related Videos
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inheritance of Chromatin Structures

